- TOGETHER FOR A SUSTAINABLE AND EFFICIENT SHARED R&D ECONOMY
- PRECISION MEDICINES AND BETTER ACCESS TO BIOTHERAPEUTICS
- ESG PERFORMANCE REPORT HIGHLIGHTS SUSTAINABILITY AS A COMPETITIVE ADVANTAGE IN CHALLENGING TIMES
Hamburg, Germany, 05 June 2023:
Evotec SE (Frankfurt Stock Exchange: EVT, ISIN: DE0005664809; NASDAQ: EVO) today presents an update on the Company’s sustainability strategy and shares details on its ESG (Environmental, Social and Governance) performance towards strengthening its competitiveness and contributing to a better future for next generations to investors and interested stakeholders at its virtual Capital Markets Day.
In a rapidly changing world, marked by unexpected opportunities and challenges like climate change but also technical and social changes with far-reaching impacts, a flexible and resilient approach is crucial. Evotec strives to shape an equitable and inclusive future for all by empowering people through new technologies, aiming to create sustainable impact. In an ever-increasingly complex world, the Company has consistently demonstrated resilience and agility over the past decade, most recently during the recovery process from a cyber-attack against Evotec in April 2023. Evotec is delivering on its commitments and reaffirming its promises and mid-term goals. Evotec’s long-term mission is to develop highly effective precision medicine collaboratively, making it more affordable and accessible to all, and to focus its business strategy on sustainable growth.
Entitled “Together for a sustainable and efficient shared R&D economy”, the virtual Capital Markets Day will provide an overview of the Company’s business and sustainability efforts highlighting
- Evotec’s sustainability strategy
- ESG performance and progress update from the Company’s Sustainability Report
- Evotec’s contribution to the Sustainable Development Goal 3 established by the United Nations (“UN SDG 3”)
- Better access to biotherapeutics through Just – Evotec Biologics’ sustainable design and manufacturing technologies
Dr Werner Lanthaler, Chief Executive Officer of Evotec, commented: “We view sustainability as the driver of innovation and efficiency. The potential of our world-leading integrated technology platforms is enormous and fundamental for an effective and affordable healthcare system of the future. It is by combining our unique business strategy with the goals and progress of our sustainability efforts that we can ensure to remain adaptable and resilient in the future to provide better access to more precise therapeutics. Embedding our sustainability strategy into our business model gives us a competitive advantage and will positively impact all patients worldwide.”
About the Capital Markets Day
Evotec hosts its virtual Capital Markets Day on 05 June 2023, starting at 02.00 pm CEST (08.00 am EST, 1.00 pm GMT). The meeting will take place via a live webcast and a recording will be available on www.evotec.com shortly after the event.